Quanterix Corp
(NAS:QTRX)
$
14.52
0.67 (4.84%)
Market Cap: 557.26 Mil
Enterprise Value: 274.27 Mil
PE Ratio: 0
PB Ratio: 1.66
GF Score: 71/100 Quanterix Corp at Goldman Sachs Global Healthcare Conference Transcript
Jun 16, 2022 / 03:40PM GMT
Release Date Price:
$16.03
(-4.53%)
Matthew Carlisle Sykes
Goldman Sachs Group, Inc., Research Division - Research Analyst
Great. Welcome, everybody. I'm Matt Sykes, the life science tools and diagnostics analyst at Goldman Sachs, and I have the pleasure of welcoming Quanterix to our conference this morning. We have Masoud Toloue, the Chief Executive Officer; and Mike Doyle, the Chief Financial Officer. Masoud, Mike, thanks for joining us today.
Michael A. Doyle
Quanterix Corporation - CFO & Treasurer
Matt, we appreciate being here.
Masoud Toloue
Quanterix Corporation - President, CEO & Director
Great to see in person.
Matthew Carlisle Sykes
Goldman Sachs Group, Inc., Research Division - Research Analyst
Yes, finally a long time. Mike, I don't know if you have any forward...
Michael A. Doyle
Quanterix Corporation - CFO & Treasurer
Quick comments that, obviously, our discussions today are covered by our forward-looking statements and it's on our
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot